Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
The Anti-dsDNA Antibody Test detects antibodies against double-stranded DNA, which are commonly associated with autoimmune diseases like Systemic Lupus Erythematosus (SLE).
This test is used to diagnose SLE, monitor disease activity, assess treatment response, and differentiate between autoimmune diseases.
No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or health conditions.
Results are typically available within 1 to 2 days after the test.
A positive result suggests the presence of antibodies associated with autoimmune activity, particularly in Systemic Lupus Erythematosus (SLE). Further evaluation is often required to confirm the diagnosis and assess disease activity.
Recovery varies, but most patients can return to normal activities within 4 to 6 weeks. Full recovery of urinary and sexual functions may take longer.
The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.
Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.
Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.
Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.
Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.